Durect Corp.
Specialty pharmaceutical company developing innovative drugs for pain and chronic diseases, with late-stage development. Learn more
Launch date
Employees
Market cap
$47.2m
Enterprise valuation
$48m (Public information from Sep 2024)
Share price
$1.35 DRRX
Cupertino California (HQ)
Authorizing premium user...